companydata.dkcompanydata.dk

GLAXOSMITHKLINE PHARMA A/S: Financial statements 2022

CVR: 27394019

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

GLAXOSMITHKLINE PHARMA A/S (CVR 27394019) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 440,283,000 and a net result of DKK 11,068,000 compared with DKK 8,984,000 the year before. That is a decrease of 1.3% compared with the year before. The profit margin was 2.5%. Equity in the 2022 report amounted to DKK 36,946,000. The solvency ratio was 31.9%. The company had 68 employees in the financial year.

Revenue
DKK 440,283,000
Gross Profit
DKK 126,161,000
Profit/Loss
DKK 11,068,000
Equity
DKK 36,946,000
Total Assets
DKK 115,803,000
Employees
68

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022440.3M126.2M11.1M36.9M68
2021445.9M111.6M9M34.8M66
2020441.7M120.3M12.3M37.8M62
2019417.4M114.3M11.1M35.5M68
2018413.8M116.3M17.5M39.4M80

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on GLAXOSMITHKLINE PHARMA A/S

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

GLAXOSMITHKLINE PHARMA A/S: The 2021 annual report is outJun 28, 2022

GLAXOSMITHKLINE PHARMA A/S has published its annual report for 2021. Revenue came to DKK 445,873,000, and the net result was DKK 8,984,000.

Patrick Gerard Connor joins the board of GLAXOSMITHKLINE PHARMA A/SJan 1, 2022

As of January 1, 2022, Patrick Gerard Connor has joined the board of directors of GLAXOSMITHKLINE PHARMA A/S.

Anne Margaret Belcher leaves the board of GLAXOSMITHKLINE PHARMA A/SJan 1, 2022

As of January 1, 2022, Anne Margaret Belcher has left the board of directors of GLAXOSMITHKLINE PHARMA A/S.

About GLAXOSMITHKLINE PHARMA A/S

GLAXOSMITHKLINE PHARMA A/S is a Danish company of the type Aktieselskab based in Vallensbæk Strand, founded in 1968. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named GLAXO DANMARK A/S and GLAXO WELLCOME A/S. The management consists of Diederik Maarten Eijsvogel. The board consists of Luciano Alves de Andrade (chair), Alastair William Jones, Diederik Maarten Eijsvogel and Helle Ann Hellberg. The company is owned by Setfirst Limited. The company has 83 employees (2026). In 2025, the company reported revenue of DKK 580,769,000 and a net result of DKK 13,123,000 compared with DKK 12,240,000 the year before. Equity in the 2025 report amounted to DKK 39,017,000.

Source: annual report 2025, Danish Business Authority